Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Gamma-PN3
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : GPN Vaccines
Deal Size : Undisclosed
Deal Type : Partnership
BioCina Expands Partnership with GPN Vaccines
Details : Under the agreement, BioCina will manufacture large-scale cGMP batches for proprietary engineered whole-cell vaccine called Gamma-PN3 against Streptococcus pneumoniae.
Product Name : Gamma-PN3
Product Type : Vaccine
Upfront Cash : Undisclosed
June 11, 2023
Lead Product(s) : Gamma-PN3
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : GPN Vaccines
Deal Size : Undisclosed
Deal Type : Partnership
Bio Cina Awarded Grant to Advance RNA Vaccines and Therapeutics
Details : The project, commencing in March will help BioCina address the post-pandemic mRNA demand for specific and essential attributes of new RNA products. It's anticipated the market will prioritize sophisticated LNP (lipid nanoparticle) formulations.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 04, 2022
Reset All
